Past Events





	Home Executive Board Past Events Upcoming Events Alumni Other Stanford Resources Stanford Law School Stanford University	Past Events March 13, 2009: Rebecca Eisenberg, Intellectual Property Treatment of Data from Clinical Trials of Drugs Rebecca S. Eisenberg is a graduate of Stanford University and Boalt Hall School of Law at the University of California, Berkeley, where she was articles editor of the California Law Review. After law school, she served as law clerk for Chief Judge Robert F. Peckham on the United States District Court for the Northern District of California and then practiced law as a litigator in San Francisco. She joined the University of Michigan Law School faculty in 1984. Feb 24, 2009: Andrew Torrance : The Patent Game! Bring your laptops to this interactive talk during which you can play "The Patent Game" -- a multi-user interactive simulation of the patent system. Win a prize for making the best decisions!The Patent Game features a database of potential innovations, an interactive interface that allows users to invent these innovations, and a network over which users interact to license, assign, infringe, and enforce patents. Answer the question-- does patent protection actually promote innovation and lead to greater societal benefits than would be possible under non-patent systems? Compare rates of innovation, productivity, and societal utility across patent, patent/open source, and commons systems. Feb 5, 2009 : Field Trip to SF Behavioral Health Court Jan 29, 2009: Adam Kolber (Stanford JD '02), University of San Diego School of Law : A Limited Defense of Clinical Placebo Deception Professor Kolber will talk about legal and ethical issues related to the clinical use of placebos and his upcoming paper, "A Limited Defense of Clinical Placebo Deception." His work on this subject was featured in a recent USA Today article. He is currently an Associate Professor at the University of San Diego School of Law, where he writes and teaches in the areas of neuroethics, bioethics and criminal law and is the founder and editor of the "Neuroethics & Law Blog." He graduated Order of the Coif from Stanford Law School, where he was an associate editor of the Stanford Law Review, and then clerked for the Honorable Chester J. Straub of the U.S. Court of Appeals for the Second Circuit and practiced law with Davis Polk & Wardwell in New York. Jan 8, 2009: John Barton Possible Compromises: New Issues in Drug Access John Barton is a professor emeritus of law at Stanford Law School. His scholarship has focused on international law concerns ranging from national defense to issues surrounding the distribution of intellectual property across the developed and undeveloped world. His current work involves the study of the transfer of technologies, including vaccine, steel, and technologies for mitigating climate change between scientifically sophisticated and developing nations, and the development of a political theory of international organization and globalization. He will discuss his new compromise proposal for drug access, which he is developing with Jeffrey Kindler (Pfizer) in response to a challenge from Senator Max Baucus. ___________________________________________________________ November 2008 Alain Enthoven Alain Enthoven is the Marriner S. Eccles Professor of Public and Private Management, emeritus, at Stanford University, and a core faculty member at Center for Health Policy/Primary Care and Outcomes Research. He is known as "the father of managed competition" and has advocated a financially integrated healthcare delivery system that relies on market-based incentives to reduce medical costs and increase economic accountability and quality of care. He is currently working on a proposal for a "Market-based Universal Health Insurance System," being developed for the Committee for Economic Development. He discussed why delivery systems matter. Morgan Lewis & Genentech Jennifer Elliott, Ph.D. - In-house Counsel, Genentech (SLS '03) and Jessie K. Minier - Associate, Morgan Lewis (SLS '02) discussed their legal practices, focusing on what they do on a day-to-day basis. Jennifer Elliott discussed what she does in-house at Genentech, where she works on Genentech's patent portfolio, and Jessie Minier discussed his practice as a corporate and securities attorney assisting clients, including biotech clients. October 2008 Sam McClure: NeuroCola: Neuroscience's ability to measure consumer preference and related policy implications Dr. McClure is a professor of psychology at Stanford University. He uses functional magnetic resonance imaging (fMRI) to investigate decision-making, particularly economic decision-making. His research interests include consumer preference, hyperbolic time discounting, and the neural substrates of reward. Dr. McClure discussed his study on the biological basis for taste preference and brand loyalty for Coca-Cola and Pepsi, how that research can be applied, and ethical concerns. Opportunities in BioLaw Career Panel Elizabeth Joh: Reclaiming “Abandoned” DNA: The Fourth Amendment and Genetic Privacy Prof. Joh is currently the Herman Phleger Visiting Professor of Law at Stanford University and is also Professor of Law at UC Davis Law School. She is an expert in the fields of policing, criminal justice privatization, and the sociology of law. Prof. Joh's research focus is in the areas of criminal law and procedure. She presented the topic of her recent law review article: RECLAIMING “ABANDONED” DNA: THE FOURTH AMENDMENT AND GENETIC PRIVACY. 100 Nw. U. L. Rev. 857 (2006). Discussion topics include questions such as whether the police should be permitted, without restriction, to target and collect the DNA that we leave behind. September 2008 BioLaw Kickoff event : BioLaw & Health Policy Society, the Center for Law & Biosciences and SIGNAL March 2008 Klaus Tanner Professor of systematic theology and ethics and director of the Interdisciplinary Center Medicine-Ethics-Law at the Martin Luther University Halle-Wittenberg “Regulating Human Embryonic Stem Cell Research: The German Debate in the Context of Europe” Co-sponsored with the Center for Law and Biosciences, and the Department of Religious Studies February 2008 Dorothy Roberts, JD Kirkland & Ellis Professor of Law, Northwestern Law School "Race, Gender and Genetic Technologies: A New Reproductive Dystopia" Co-sponsored with the Black Law Students Association, Women of Color Action Network, and Women of Stanford Law Katherine Hayes, JD Vice President, Jennings Policy Strategies, Inc. “Presidential Politics and Health Care Reform” Co-sponsored with the American Constitution Society January 2008 Philip Zimbardo, PhD Professor (emeritus) of Psychology, Stanford University “The Psychology of Evil: The Lucifer Effect in Action” Co-sponsored with the American Constitution Society and Criminal Law Society November 2007 Alain C. Enthoven, Ph.D. Professor of Public and Private Management (emeritus), Core faculty member at Center for Health Policy/Primary Care and Outcomes Research, Stanford University “A Market-Based Universal Health Insurance System” August Moretti, J.D, Senior Vice President and CFO, Alexza Pharmaceuticals “The State of the Biotech IPO Market” Sean Johnston, J.D. ‘89, Ph.D. In-House Counsel and Vice President, Genentech “Current Issues in Intellectual Property and the Biotechnology Industry” John Barton, JD George E. Osborne Professor of Law, Emeritus, Stanford Law School “Access to Pharmaceuticals in the Developing World” Co-Sponsored with the International Law Society October 2007 David Hyman, J.D., M.D. Richard W. and Marie L. Corman Professor, and Director, Epstein Program in Health Law and Policy, University of Illinois School of Law “Do Defendants Pay What Juries Award?: Post-Verdict Haircuts in Texas Medical Malpractice” September 2007 Hank Greely, J.D. Deane F. and Kate Edelman Johnson Professor of Law, Stanford Law School “Law and the Biosciences: Fun, Travel, and Adventure” April 2007 Leslie E. Wolf, JD, MPH (BA’88) Associate Professor of Law at Georgia State University’s College of Law “Laws Relating to Routine HIV Testing” Katherine Ku, MS Director, Office of Technology Licensing, Stanford “Current Issues in Technology Licensing” Michelle Oberman, JD, MPH Professor of Law, Santa Clara University School of Law “Where Stem Cell Research Meets Abortion Politics: Buying and Selling Human Oocytes” March 2007 Andrew Fire, PhD Nobel Laureate and Stanford Professor of Pathology and Genetics “RNA Interference, Law, and Business” Simon Wakeman, PhD, LLB Fellow, Center for Law & Biosciences, Stanford Law School “The Evolution of Contracting Arrangements in the Biotech Industry” February 2007 Robin Feldman, JD Professor and Director of the Law and Biosciences Project, UC Hastings Herman Phleger Visiting Professor, Stanford Law School (2006-07) “Rethinking Rights in Biospace” Victor Fuchs, MA, PhD Henry J. Kaiser, Jr., Professor of Economics and of Health Research and Policy, Emeritus, Stanford “The Economics of Health Policy” Robin Tucker, JD, MBA Associate, Wilson Sonsini Goodrich & Rosati “A Career in Life Sciences, Health Care, and Start-Ups November 2006 Irv Weissman Stanford Professor and Founder of Stem Cells, Inc. “The State of Stem Cell Research” Carol Francis, J.D., Ph.D. Partner, Bozicevic, Field, and Francis LLP October 2006 David Magnus, PhD Director, Stanford Center for Biomedical Ethics “Current Issues in Bioethics” John Barton, JD George E. Osborne Professor of Law, Emeritus “The Pharmaceutical Industry in an International Market” September 2006 John Freund, M.D., M.B.A. Founder, Skyline Ventures “Founding a billion dollar company: Intuitive Surgical. Opportunities in Biomedical Techonology” Mark Lemley, JD William H. Neukom Professor of Law, Stanford Law School “IP and the Supreme Court’s 2006 Docket” Hank Greely, JD Deane F. and Kate Edelman Johnson Professor of Law, Stanford Law School “Introduction to BioLaw, SHLAPS, and Health Law Opportunities at Stanford Law School. a.k.a. Welcome 1Ls!”

Disclaimer: Sites may include unmoderated forums containing the personal opinions and other expressions of the persons who post entries on a wide range of topics. Neither the content of these Sites, nor the links to other web sites, are screened, approved, reviewed or endorsed by Stanford University and Stanford Law School.